Geodon Paragraph IV Certification
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with a Paragraph IV certification for Pfizer's atypical antipsychotic Geodon (ziprasidone) was filed Feb. 7, according to FDA's April 1 updated list of filings